Cetuximab, a monoclonal antibody targeting the epidermal growth factor receptor, in combination with gemcitabine for advanced pancreatic cancer: a multicenter phase II Trial (Q33361488)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Cetuximab, a monoclonal antibody targeting the epidermal growth factor receptor, in combination with gemcitabine for advanced pancreatic cancer: a multicenter phase II Trial |
scientific article |
Statements
1 reference
Cetuximab, a monoclonal antibody targeting the epidermal growth factor receptor, in combination with gemcitabine for advanced pancreatic cancer: a multicenter phase II Trial (English)
1 reference
James L Abbruzzese
1 reference
Henry Q Xiong
1 reference
Arthur Rosenberg
1 reference
Albert LoBuglio
1 reference
William Schmidt
1 reference
Robert A Wolff
1 reference
John Deutsch
1 reference
Michael Needle
1 reference
1 July 2004
1 reference
1 reference
22
1 reference
13
1 reference
2610-2616
1 reference
Identifiers
1 reference
1 reference